A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

BACKGROUND: The raising prevalence of type-2 diabetes mellitus and obesity has been recognized as a major problem for public health, affecting both developed and developing countries. Impaired fasting plasma glucose has been previously associated with endothelial dysfunction, higher levels of inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Jaramillo, Patricio, Pradilla, Lina P, Lahera, Vicente, Sieger, Federico A Silva, Rueda-Clausen, Christian F, Márquez, Gustavo A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1594582/
https://www.ncbi.nlm.nih.gov/pubmed/16959033
http://dx.doi.org/10.1186/1745-6215-7-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1594582/
https://www.ncbi.nlm.nih.gov/pubmed/16959033
http://dx.doi.org/10.1186/1745-6215-7-28

Ejemplares similares